These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
348 related items for PubMed ID: 22395029
1. Comparative analysis of hepatopulmonary shunt obtained from pretherapy 99mTc MAA scintigraphy and post-therapy 90Y Bremsstrahlung imaging in 90Y microsphere therapy. Jha AK, Zade AA, Rangarajan V, Purandare N, Shah SA, Agrawal A, Kulkarni SS, Shetty N. Nucl Med Commun; 2012 May; 33(5):486-90. PubMed ID: 22395029 [Abstract] [Full Text] [Related]
2. Predictive Value of 99mTc-MAA SPECT for 90Y-Labeled Resin Microsphere Distribution in Radioembolization of Primary and Secondary Hepatic Tumors. Ilhan H, Goritschan A, Paprottka P, Jakobs TF, Fendler WP, Todica A, Bartenstein P, Hacker M, Haug AR. J Nucl Med; 2015 Nov; 56(11):1654-60. PubMed ID: 26315830 [Abstract] [Full Text] [Related]
3. Predictive value of intratumoral 99mTc-macroaggregated albumin uptake in patients with colorectal liver metastases scheduled for radioembolization with 90Y-microspheres. Ulrich G, Dudeck O, Furth C, Ruf J, Grosser OS, Adolf D, Stiebler M, Ricke J, Amthauer H. J Nucl Med; 2013 Apr; 54(4):516-22. PubMed ID: 23447653 [Abstract] [Full Text] [Related]
4. A simple method for estimating dose delivered to hepatocellular carcinoma after yttrium-90 glass-based radioembolization therapy: preliminary results of a proof of concept study. Kokabi N, Galt JR, Xing M, Camacho JC, Barron BJ, Schuster DM, Kim HS. J Vasc Interv Radiol; 2014 Feb; 25(2):277-87. PubMed ID: 24461133 [Abstract] [Full Text] [Related]
5. Hepatopulmonary Shunt Ratio Verification Model for Transarterial Radioembolization. Yeyin N, Kesmezacar FF, Tunçman D, Demir Ö, Uslu-Beşli L, Günay O, Demir M. Curr Radiopharm; 2024 Feb; 17(3):276-284. PubMed ID: 38288829 [Abstract] [Full Text] [Related]
6. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. Hamami ME, Poeppel TD, Müller S, Heusner T, Bockisch A, Hilgard P, Antoch G. J Nucl Med; 2009 May; 50(5):688-92. PubMed ID: 19372479 [Abstract] [Full Text] [Related]
7. 99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization. Wondergem M, Smits ML, Elschot M, de Jong HW, Verkooijen HM, van den Bosch MA, Nijsen JF, Lam MG. J Nucl Med; 2013 Aug; 54(8):1294-301. PubMed ID: 23749996 [Abstract] [Full Text] [Related]
8. 90 Y SPECT/CT quantitative study and comparison of uptake with pretreatment 99 m Tc-MAA SPECT/CT in radiomicrosphere therapy. Debebe SA, Adjouadi M, Gulec SA, Franquiz J, McGoron AJ. J Appl Clin Med Phys; 2019 Feb; 20(2):30-42. PubMed ID: 30628156 [Abstract] [Full Text] [Related]
10. Evaluation of factors affecting tumor response and survival in patients with primary and metastatic liver cancer treated with microspheres. Demirelli S, Erkilic M, Oner AO, Budak ES, Gunduz S, Ozgur O, Bozcuk H, Sindel HT, Boz A. Nucl Med Commun; 2015 Apr; 36(4):340-9. PubMed ID: 25563137 [Abstract] [Full Text] [Related]
12. Outpatient single-session yttrium-90 glass microsphere radioembolization. Gates VL, Marshall KG, Salzig K, Williams M, Lewandowski RJ, Salem R. J Vasc Interv Radiol; 2014 Feb; 25(2):266-70. PubMed ID: 24332243 [Abstract] [Full Text] [Related]
13. PET/CT-Based Dosimetry in 90Y-Microsphere Selective Internal Radiation Therapy: Single Cohort Comparison With Pretreatment Planning on (99m)Tc-MAA Imaging and Correlation With Treatment Efficacy. Song YS, Paeng JC, Kim HC, Chung JW, Cheon GJ, Chung JK, Lee DS, Kang KW. Medicine (Baltimore); 2015 Jun; 94(23):e945. PubMed ID: 26061323 [Abstract] [Full Text] [Related]
14. Intraarterial Hepatic SPECT/CT Imaging Using 99mTc-Macroaggregated Albumin in Preparation for Radioembolization. Gates VL, Singh N, Lewandowski RJ, Spies S, Salem R. J Nucl Med; 2015 Aug; 56(8):1157-62. PubMed ID: 26089551 [Abstract] [Full Text] [Related]
15. (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres. Elschot M, Nijsen JF, Lam MG, Smits ML, Prince JF, Viergever MA, van den Bosch MA, Zonnenberg BA, de Jong HW. Eur J Nucl Med Mol Imaging; 2014 Oct; 41(10):1965-75. PubMed ID: 24819055 [Abstract] [Full Text] [Related]
16. Is a Technetium-99m Macroaggregated Albumin Scan Essential in the Workup for Selective Internal Radiation Therapy with Yttrium-90? An Analysis of 532 Patients. Sancho L, Rodriguez-Fraile M, Bilbao JI, Beorlegui Arteta C, Iñarrairaegui M, Moran V, Sangro B. J Vasc Interv Radiol; 2017 Nov; 28(11):1536-1542. PubMed ID: 28916345 [Abstract] [Full Text] [Related]
18. Computed tomography hepatic arteriography has a hepatic falciform artery detection rate that is much higher than that of digital subtraction angiography and 99mTc-MAA SPECT/CT: implications for planning 90Y radioembolization? Burgmans MC, Too CW, Kao YH, Goh AS, Chow PK, Tan BS, Tay KH, Lo RH. Eur J Radiol; 2012 Dec; 81(12):3979-84. PubMed ID: 22954411 [Abstract] [Full Text] [Related]
19. Planning dosimetry for 90 Y radioembolization with glass microspheres: Evaluating the fidelity of 99m Tc-MAA and partition model predictions. Thomas MA, Mahvash A, Abdelsalam M, Kaseb AO, Kappadath SC. Med Phys; 2020 Oct; 47(10):5333-5342. PubMed ID: 32790882 [Abstract] [Full Text] [Related]